Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amber L Beitelshees

Showing results (11-20 of 127) with videos related to

Pageof 13
Sort By:
Diabetes Care|March 1, 2007
NOS3 polymorphisms are associated with arterial stiffness in children with type 1 diabetesIssam Zineh, Amber L Beitelshees, Michael J Haller
The Journal of Clinical Investigation|January 19, 2021
Pharmacological treatment of hyperglycemia in type 2 diabetesSimeon I Taylor, Zhinous Shahidzadeh Yazdi, Amber L Beitelshees
Diabetes|May 22, 2019
Sodium-Glucose Cotransporter 2 Inhibitors: A Case Study in Translational ResearchAmber L Beitelshees, Bruce R Leslie, Simeon I Taylor
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|October 24, 2006
Common laboratory methods in pharmacogenomics studiesChristina L Aquilante, Issam Zineh, Amber L Beitelshees, et al.
Diabetes Care|December 19, 2008
Serum monocyte chemoattractant protein-1 concentrations associate with diabetes status but not arterial stiffness in children with type 1 diabetesIssam Zineh, Amber L Beitelshees, Janet H Silverstein, et al.
Pharmacotherapy|March 31, 2012
Cost-effectiveness of cytochrome P450 2C19 genotype screening for selection of antiplatelet therapy with clopidogrel or prasugrelEmily S Reese, C Daniel Mullins, Amber L Beitelshees, et al.
The Lancet. Diabetes & Endocrinology|October 6, 2019
SGLT2 inhibitors as adjunctive therapy for type 1 diabetes: balancing benefits and risksSimeon I Taylor, Jenny E Blau, Kristina I Rother, et al.
Pharmacotherapy|September 2, 2006
Discordant beta-blocker effects on clinic, ambulatory, resting, and exercise hemodynamics in patients with hypertensionAmber L Beitelshees, Issam Zineh, Hossein N Yarandi, et al.
Pharmacogenetics and Genomics|May 15, 2007
Single nucleotide polymorphism discovery and haplotype analysis of Ca2+-dependent K+ channel beta-1 subunitYan Gong, Amber L Beitelshees, Jennifer Wessel, et al.
The Journal of Clinical Endocrinology and Metabolism|March 14, 2024
Critical Role for 24-Hydroxylation in Homeostatic Regulation of Vitamin D MetabolismZhinous Shahidzadeh Yazdi, Elizabeth A Streeten, Hilary B Whitlatch, et al.
Pageof 13

Showing results (11-20 of 127) with videos related to

Sort By:
Pageof 13
Diabetes Care|March 1, 2007
NOS3 polymorphisms are associated with arterial stiffness in children with type 1 diabetesIssam Zineh, Amber L Beitelshees, Michael J Haller
The Journal of Clinical Investigation|January 19, 2021
Pharmacological treatment of hyperglycemia in type 2 diabetesSimeon I Taylor, Zhinous Shahidzadeh Yazdi, Amber L Beitelshees
Diabetes|May 22, 2019
Sodium-Glucose Cotransporter 2 Inhibitors: A Case Study in Translational ResearchAmber L Beitelshees, Bruce R Leslie, Simeon I Taylor
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|October 24, 2006
Common laboratory methods in pharmacogenomics studiesChristina L Aquilante, Issam Zineh, Amber L Beitelshees, et al.
Diabetes Care|December 19, 2008
Serum monocyte chemoattractant protein-1 concentrations associate with diabetes status but not arterial stiffness in children with type 1 diabetesIssam Zineh, Amber L Beitelshees, Janet H Silverstein, et al.
Pharmacotherapy|March 31, 2012
Cost-effectiveness of cytochrome P450 2C19 genotype screening for selection of antiplatelet therapy with clopidogrel or prasugrelEmily S Reese, C Daniel Mullins, Amber L Beitelshees, et al.
The Lancet. Diabetes & Endocrinology|October 6, 2019
SGLT2 inhibitors as adjunctive therapy for type 1 diabetes: balancing benefits and risksSimeon I Taylor, Jenny E Blau, Kristina I Rother, et al.
Pharmacotherapy|September 2, 2006
Discordant beta-blocker effects on clinic, ambulatory, resting, and exercise hemodynamics in patients with hypertensionAmber L Beitelshees, Issam Zineh, Hossein N Yarandi, et al.
Pharmacogenetics and Genomics|May 15, 2007
Single nucleotide polymorphism discovery and haplotype analysis of Ca2+-dependent K+ channel beta-1 subunitYan Gong, Amber L Beitelshees, Jennifer Wessel, et al.
The Journal of Clinical Endocrinology and Metabolism|March 14, 2024
Critical Role for 24-Hydroxylation in Homeostatic Regulation of Vitamin D MetabolismZhinous Shahidzadeh Yazdi, Elizabeth A Streeten, Hilary B Whitlatch, et al.
Pageof 13